AzTrials
AzTrials

Brain MappingNCT01375595

Brain Areas Involved in Sound and Spoken Word Memory

An observational study of Brain Mapping and Language Disorder, run by National Institute of Neurological Disorders and Stroke (NINDS) at 1 site in United States.

Terminated

Stopped early. The study ended before it was planned to and will not resume.

Official record
Search all trials

Trial summary

Background: Studies have shown that animals such as monkeys and dogs have excellent sight and touch memory but perform poorly on sound memory tasks. Human brains have certain areas that are important for speaking and understanding language. These areas may be involved in sound and spoken word memory. Read more about this study

Who is it for?
Ages 18 to 40 yearsHealthy volunteers can take part
Conditions the study is for
Brain Mapping, Language Disorder, Adult
How many people
45 participants
Where
1 siteUnited States
Study dates
26 May 2011to 30 Oct 2015
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 40 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • To be eligible for this research study participants must:
  • Be between the ages of 18 and 50 years of age
  • Be free of any neurologic condition that might affect performance of the tasks in these experiments
  • Be right handed
  • Be native English speakers
  • Have a finished high-school education or equivalent, such as GED

Who cannot join

  • Participants will be excluded from this research study if they:
  • Are taking medications that include antidepressants, anxiolytics, anticonvulsants, antipsychotics, antiparkinson, hypnotics, stimulants, and/or antihistamines
  • Have a diagnosed neurologic or psychiatric condition
  • Have a history of seizure disorder
  • Have implanted devices such as pacemakers, medication pumps, or defibrillators, metal in the cranium except the mouth, intracardiac lines, history of shrapnel injury or any other condition/device that may contraindicate or preclude the acquisition of MRI
  • Have severe back pain or any other condition which might prevent them from lying flat for up to 1 hour
Show all 10Show fewer
  • Have Claustrophobia (a fear of tight spaces), which prevents them from lying still in a tight or small space for up to 1 hour
  • Are currently pregnant
  • Have known hearing loss
  • Have an alcohol or substance abuse problem as determined by the screening we will do

Trial locations and contacts

1 site in 1 country.

United States1 site
  • National Institutes of Health Clinical Center, 9000 Rockville Pike

    Bethesda, Maryland, 20892

Other trials in United States

About this study

Official title: The Role of the Inferior Frontal Gyrus in Long-Term Auditory Memory a rTMS Study

Background:

  • Studies have shown that animals such as monkeys and dogs have excellent sight and touch memory but perform poorly on sound memory tasks. Human brains have certain areas that are important for speaking and understanding language. These areas may be involved in sound and spoken word memory. Researchers want to study these areas of the brain to find out if the memory for sounds requires brain structures that are usually associated with language learning and are unique to humans.
Read more

Objectives:

  • To use magnetic resonance imaging to study areas of the brain involved in sound memory.

Eligibility:

  • Healthy right-handed volunteers between 18 and 50 years of age. They must be native English speakers and have completed high school.

Design:

  • The study requires a screening visit and 1 or 2 study visits to the National Institutes of Health Clinical Center.
  • At the screening visit, volunteers will have a medical history taken. They will also have physical and neurological exams, and complete a questionnaire. Women of childbearing age will give a urine sample. Participants who have not had a magnetic resonance imaging (MRI) scan in the past year will have one at this visit.
  • At the second visit, participants will have tests of sound memory. They will listen to a set of nonsense words spoken through earphones and memorize the words. Then they will listen to the words again to judge if the words were part of the earlier list. Participants will have a 1 hour break, then do the sound memory test again. During the second test they will have repetitive transcranial magnetic stimulation (rTMS), which stimulates different regions of the brain.
  • If the group results from the testing sessions are positive, there will be a third visit. At this visit, participants will have a sound perception test. They will listen to words spoken through earphones and judge whether the words in the pair are the same or different. Participants will have rTMS during these tests as well.
Read the detailed description

Objective:

Humans are the only animals that use language to communicate with each other. Among many other requirements, humans need excellent auditory long-term memory to be able to master the complicated task of learning a language. It is still not completely understood which brain regions are involved in transferring auditory stimuli into long-term memory. The goal of this research proposal is to examine whether brain structures that are known to be essential in language production also play an important role in encoding auditory stimuli into long-term memory.

Study population:

We propose using repetitive transcranial magnetic stimulation (rTMS) to examine the role of

frontal and temporo-parietal cortical areas in the storage of auditory stimuli in long-term memory. The whole study will comprise three experiments. Each of the three experiments will consist of one to three sessions. Sessions 1 and 2 will be compulsory in every experiment. Session 3 will only be required if positive results are obtained in session 2. Every participant can only participate in one of the three planned experiments.

In Experiment 1, we will investigate the potential role of Broca s area in auditory memory. If we find that rTMS in Broca s area interferes with performance on the memory task, we will conduct a control (session 3) to determine whether or not the impairment was actually due to interference with stimulus perception rather than with memory, per se. We will conduct Experiment 2 to investigate the possible role of Wernicke s region in auditory memory. We will conduct Experiment 3 to investigate the role of the ventral premotor cortex (PMv) in auditory memory.

In experiment 2 and 3 we will also conduct the same control session 3, as in Experiment 1 if the rTMS impairs performance on the auditory memory task. All experiments will consist of two sessions and an additional, third session if rTMS-induced impairment is found. In that case all participants will be called back for the control experiment. During session 1, a neurological examination will be performed and a clinical, anatomical, and functional MRI (Magnetic Resonance Imaging) will be taken (functional MRI for second repeat of experiment 1 and for experiment 3). In session 2, rTMS will be used in an attempt to temporarily disrupt the function of Broca s area (experiment 1), the TPJ (experiment 2) or PMv (experiment 3) while participants are performing an auditory recognition memory task. By temporarily disrupting cortical functioning in those localized regions, we will be able to determine whether or not their function is crucial for encoding auditory stimuli into long-term memory. In the control session, to be conducted only if the experimental task yields a positive result (i.e., impairment), we will test auditory perception by asking participants to make same/different judgments on stimulus pairs (similar to those used in session 2) presented with a very short delay while using the same rTMS routine as in session 2.

By amendment, we wish to expand session 1 to include functional MRI (fMRI) imaging designed to identify and refine the targets for disruption by rTMS in the subsequent session: Broca s area (experiment 1), and PMv (experiment 3). Specifically, we intend to (1) repeat Experiment 1 of the approved protocol using fMRI localization in an additional 15 subjects, and (2) proceed with Experiment 3 as described in the original protocol, also with the addition of fMRI localization. Initial results in experiment 1 (Broca s area) fell just short of significance, possibly because anatomical landmarks are inconsistent between subjects (e.g., Amunts et al., 1999); an fMRI localizer in each subject could reduce this variability. Unlike in the previous protocol, session 1 can not be skipped if the subject has had a neurological exam and MRI in the past year (the exam may be skipped, but all subjects will need the fMRI). The maximum number of sessions per experiment will remain unchanged at three: 1) intake exam and anatomical/functional MRI, 2) rTMS, and 3) a control session only if a significant effect of rTMS is observed.

By amendment, we also wish to consider the three experiments to be independent, rather than each contingent on the outcome of the previous experiment(s). As outlined below (sections 2.3-2.5), experimental evidence implicates all three regions in the auditory-motor network under study. Preliminary evidence indicates a positive effect in experiment 2 (the TPJ), but this does not render experiment 3 moot. Therefore we wish to apply fMRI-targeted rTMS to Broca s area, and PMv, in independent experiments.

Outcome measures:

In session 2, the primary outcome measure will be the number of correctly remembered auditory stimuli. Secondary output will be reaction time during the recognition phase of the experiment.

In the control experiment (if conducted) the primary outcome measure will be the number of correct same/different judgments and, again, reaction time will be the secondary measure.

Keywords
Working Memory, Repetitive TMS (rTMS), Language, Healthy Volunteer, HV
Medical subject headings
Language Disorders, Memory Disorders, Language

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The primary outcome of this study is the error rate during the recognition memory task. The error rate is defined by the amount of stimuli that are correctly classified as familiar or unfamiliar.

Secondary outcomes (1)
  1. The secondary outcome measure of this study is the reaction time of participants to make judgments concerning the familiarity during the recognition memory task.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Jun 2011 (estimated)
  2. Study start26 May 2011
  3. Study completion30 Oct 2015

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Time perspective
Prospective
Enrolment
45 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01375595
Sponsor's protocol ID
110182
Other IDs
11-N-0182
Status last verified
30 Oct 2015
First submitted
16 Jun 2011
Last updated
2 Jul 2017
Results posted
No

Publications

  • Aggleton JP, Brown MW. Interleaving brain systems for episodic and recognition memory. Trends Cogn Sci. 2006 Oct;10(10):455-63. doi: 10.1016/j.tics.2006.08.003. Epub 2006 Aug 28.

    PubMed 16935547
  • Andoh J, Artiges E, Pallier C, Riviere D, Mangin JF, Cachia A, Plaze M, Paillere-Martinot ML, Martinot JL. Modulation of language areas with functional MR image-guided magnetic stimulation. Neuroimage. 2006 Jan 15;29(2):619-27. doi: 10.1016/j.neuroimage.2005.07.029. Epub 2005 Sep 15.

    PubMed 16168674
  • Alloway TP, Alloway RG. Investigating the predictive roles of working memory and IQ in academic attainment. J Exp Child Psychol. 2010 May;106(1):20-9. doi: 10.1016/j.jecp.2009.11.003. Epub 2009 Dec 16.

    PubMed 20018296

Questions about this trial

What is this clinical trial studying?

An observational study of Brain Mapping and Language Disorder, run by National Institute of Neurological Disorders and Stroke (NINDS) at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: stopped early, as of the sponsor's last update on 2 Jul 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was stopped early. Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The primary outcome of this study is the error rate during the recognition memory task. The error rate is defined by the amount of stimuli that are correctly classified as familiar or unfamiliar.. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01375595, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Jul 2017; AzTrials last refreshed its copy on 6 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in